Wednesday, November 03, 2021 1:29:50 AM
This is obvious a bitter battle between anti Nader shareholders and Nader.
I wont take up a sword in that battle. I fight for CYDY. If 50.00000001% of all legal shares vote no to the 200,000,000 shares;
Nader or who ever is in charge has one option. There is no more time on the clock. I new management team andwould take at least another 30 days for a new vote. Only a nonsecured loan would negate the reverse split need.
That option is, ONE MORE TIME, a reverse split. Those that disagree, FINE. Reap the rewards. The share market valuation of 1.18$ will be close to 50 cents the day after a 1 new for 4 old, worse if a 1 new for 10 old.
Our short sellers are rooting for a defeat of the 200 million.
What would I seek if I was the control person, or in this case the CEO? I would shove it up the no voters nose. 1 new for 10 old. I would encourage the malcontents to move along. Sell out. Any shareholder that cant see this has bitter emotional bonds that they cant see the facts before them.
I am in shock that what I thought were hard core investors have this Nader chip on their shoulder.
The 200,000,000 shares is a terrible pill I must swallow. A few of my pals know my exact opinion.
I am a pragmatic investor. Consider this the most important subject I have considered.
I wont take up a sword in that battle. I fight for CYDY. If 50.00000001% of all legal shares vote no to the 200,000,000 shares;
Nader or who ever is in charge has one option. There is no more time on the clock. I new management team andwould take at least another 30 days for a new vote. Only a nonsecured loan would negate the reverse split need.
That option is, ONE MORE TIME, a reverse split. Those that disagree, FINE. Reap the rewards. The share market valuation of 1.18$ will be close to 50 cents the day after a 1 new for 4 old, worse if a 1 new for 10 old.
Our short sellers are rooting for a defeat of the 200 million.
What would I seek if I was the control person, or in this case the CEO? I would shove it up the no voters nose. 1 new for 10 old. I would encourage the malcontents to move along. Sell out. Any shareholder that cant see this has bitter emotional bonds that they cant see the facts before them.
I am in shock that what I thought were hard core investors have this Nader chip on their shoulder.
The 200,000,000 shares is a terrible pill I must swallow. A few of my pals know my exact opinion.
I am a pragmatic investor. Consider this the most important subject I have considered.
Recent CYDY News
- CytoDyn Announces First Patient Dosed in Expanded Access Program for Leronlimab in Triple-Negative Breast Cancer • GlobeNewswire Inc. • 04/27/2026 12:30:00 PM
- CytoDyn to Host Investor Webcast • GlobeNewswire Inc. • 04/23/2026 12:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/22/2026 09:21:50 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/22/2026 12:30:00 PM
- CytoDyn Completes Enrollment in Phase 2 Metastatic Colorectal Cancer Study • GlobeNewswire Inc. • 04/21/2026 08:10:00 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/20/2026 12:30:00 PM
- CytoDyn to Present at the AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/14/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/08/2026 09:15:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/08/2026 12:30:28 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/25/2026 09:16:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:24:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:23:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:22:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:21:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 09:15:24 PM
- CytoDyn Presents at AACR Special Conference in Cancer Research: Brain Cancer • GlobeNewswire Inc. • 03/24/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/09/2026 09:15:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2026 01:35:02 PM
- CytoDyn Closes $17.5 Million Financing to Fund Continued Development of Leronlimab • GlobeNewswire Inc. • 03/05/2026 01:30:00 PM
- CytoDyn Presents Novel CCR5 Inhibition Mechanisms and Long-Term Survival Signals for Leronlimab in Metastatic Breast Cancer at AACR Immuno-Oncology Conference • GlobeNewswire Inc. • 02/20/2026 01:30:00 PM
- CytoDyn Announces Funding and Initiation of Expanded Access Program for Patients with Triple-negative Breast Cancer • GlobeNewswire Inc. • 01/27/2026 01:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/09/2026 10:15:22 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/09/2026 01:30:45 PM
